The FDA first approved Dignitana’s DigniCap Cooling System in 2015 for breast cancer patients. The cooling cap may now also be used for cancer patients with solid tumors.
Patients wear the cap during chemotherapy sessions. The device circulates cold liquid to cool the scalp and restrict blood flow to the head, thereby limiting the amount of chemotherapy that reaches the scalp and harms hair follicles.
More articles on supply chain:
Precision benchmarking a panacea for purchased services savings
Vertex Pharma makes 1st price hike on cystic fibrosis drug
Novo Nordisk recalls insulin pen cartridge holders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
